IMPROVING SEXUAL AROUSAL, SEXUAL DESIRE, ORGASM AND/OR PLEASURE FOLLOWING INTRAVAGINAL PRASTERONE (DHEA) ADMINISTRATION IN WOMEN INDEPENDENTLY OF OR NOT SUFFERING FROM DYSPAREUNIA OR OTHER SYMPTOMS OF VULVOVAGINAL ATROPHY

摘要

PROBLEM TO BE SOLVED: To treat sexual arousal, sexual desire and/or orgasm problems in women not suffering from dyspareunia or symptoms of vulvovaginal atrophy and also in premenopausal women having no symptoms/signs of vaginal atrophy.SOLUTION: Intravaginal DHEA is used for the treatment of at least one condition selected from the group consisting of female hypoactive sexual desire disorder, female sexual arousal disorder, female orgasm disorder and female sexual interest arousal disorder in a woman who is (1) not suffering from symptoms of vulvovaginal atrophy and/or (2) not suffering moderate to severe dyspareunia.SELECTED DRAWING: Figure 1